Gabriela Burian

Gabriela Burian has extensive experience in the medical field, beginning with a role as a Physician, General & Family Practice, Epidemiology at Municipal Hospital Orsova in 1990. Gabriela then worked as an Ophthalmic Medical Technician at Georgia Retina, PC in 1996, and as a Clinical Research Manager and Faculty Ophthalmology Masters at Emory University in 2000. In 2005, they joined Novartis Pharma AG as a Therapeutic Area Head Ophthalmology/ Global Program Medical Director, Global Program Medical Director/ Ophthalmology/ Lucentis, Medical Scientific Expert, and Sr. Clinical Research Scientist/ Clinical Communications Leader. In 2013, they moved to Roche as an Early Development Program Leader Ophthalmology. In 2014, they became Chief Medical Officer at Iconic Therapeutics and Executive Advisor at GBBiomed Advisors GmbH. In 2017, they took on the role of Consulting Chief Medical Officer at Novaliq GmbH, and in 2021 they became Consulting Chief Medical Officer at Dopavision.

Gabriela Burian received their MD from Victor Babeş University of Medicine and Pharmacy, Timişoara between 1984 and 1990, majoring in General Medicine. Gabriela then went on to pursue an MPH in Epidemiology at Emory University from 2000 to 2003.